Active substance
Ketorolac
- SFDA 7
- US FDA 68
- Health Canada 11
- US price lines 7
- NHS prices 2
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ACULAR LS 0.4% OPHTHALMIC SOLUTION | 0.4 % | Ophthalmic solution · Ophthalmic use | 1 Dropper Container | SAR 19.20 | NCE · Prescription | AbbVie Inc | Valid |
| ACUVAIL ophthalmic solution | 0.45 % | Ophthalmic solution · Ophthalmic use | 30 Single Dose Container | SAR 35.45 | NCE · Prescription | AbbVie Inc | Valid |
| KETOTHROM | 30 mg/ml | Solution for injection · Intravenous use | 6 Ampoule | SAR 35.20 | NCE · Prescription | PT. Novell Pharmaceutical Laboratories | Valid |
| Ketorolac BOS | 30 mg/ml | Injection · Intramuscular and intravenous use | 25 Vial | SAR 313.25 | NCE · Prescription | Boston Oncology Arabia | Valid |
| trolac | 10 mg/ml | Solution for injection · Intramuscular and intravenous use | 5 Ampoule | SAR 19.70 | Generic · Prescription | Pharma Pharmaceutical Industries (PPI) | Valid |
| trolac | 30 mg/ml | Solution for injection · Intramuscular and intravenous use | 5 Ampoule | SAR 21.70 | Generic · Prescription | Pharma Pharmaceutical Industries (PPI) | Valid |
| ACULAR 0.5% OPHTHALMIC SOLUTION | 0.5 % | Ophthalmic solution · Ophthalmic use | 1 Dropper Container | SAR 19.20 | NCE · Prescription | ALLERGAN PHARMACEUTICALS LTD | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ALLERGIC CONJUCTIVITIS (AC); CYSTOID MACULAR EDEMA; NON-INFECTIOUS UVEITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ACULAR | 0.5% | solution/drops · ophthalmic | ABBVIE | Prescription | 9 Nov 1992 |
| KETOROLAC TROMETHAMINE | 10MG | tablet · oral | TEVA | Prescription | 16 May 1997 |
| KETOROLAC TROMETHAMINE | 10MG | tablet · oral | MYLAN | Prescription | 16 May 1997 |
| KETOROLAC TROMETHAMINE | 15MG/ML; 30MG/ML | injectable · injection | HOSPIRA | Prescription | 5 Jun 1997 |
| KETOROLAC TROMETHAMINE | 15MG/ML; 30MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 11 Jan 2002 |
| ACULAR LS | 0.4% | solution/drops · ophthalmic | ABBVIE | Prescription | 30 May 2003 |
| KETOROLAC TROMETHAMINE | 15MG/ML; 30MG/ML; 60MG/2ML | injectable · injection | HIKMA PHARMS | Prescription | 21 Jul 2004 |
| KETOROLAC TROMETHAMINE | 60MG/2ML | injectable · injection | AMPHASTAR PHARM | Prescription | 21 Jul 2004 |
| KETOROLAC TROMETHAMINE | 60MG/2ML | injectable · injection | GLAND PHARMA LTD | Prescription | 27 Jul 2004 |
| KETOROLAC TROMETHAMINE | 30MG/ML | injectable · injection | SANDOZ | Prescription | 6 Oct 2004 |
| KETOROLAC TROMETHAMINE | 15MG/ML; 30MG/ML | injectable · injection | APOTEX | Prescription | 27 Mar 2007 |
| ACUVAIL | 0.45% | solution/drops · ophthalmic | ABBVIE | Prescription | 22 Jul 2009 |
| KETOROLAC TROMETHAMINE | 0.5% | solution/drops · ophthalmic | APOTEX | Prescription | 5 Nov 2009 |
| KETOROLAC TROMETHAMINE | 0.5% | solution/drops · ophthalmic | SANDOZ | Prescription | 5 Nov 2009 |
| SPRIX | 15.75MG/SPRAY | spray, metered · nasal | COSETTE | Prescription | 14 May 2010 |
| KETOROLAC TROMETHAMINE | 15MG/ML; 30MG/ML | injectable · injection | SAGENT PHARMS INC | Prescription | 27 Nov 2013 |
| KETOROLAC TROMETHAMINE | 30MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 7 Oct 2015 |
| KETOROLAC TROMETHAMINE | 15MG/ML; 30MG/ML | injectable · injection | GLAND | Prescription | 1 Nov 2016 |
| KETOROLAC TROMETHAMINE | 30MG/ML; 15MG/ML | injectable · injection | BAXTER HLTHCARE CORP | Prescription | 15 Sep 2017 |
| KETOROLAC TROMETHAMINE | 10MG | tablet · oral | CHARTWELL RX | Prescription | 16 Aug 2018 |
| KETOROLAC TROMETHAMINE | 0.5% | solution/drops · ophthalmic | MICRO LABS LTD INDIA | Prescription | 5 Apr 2019 |
| KETOROLAC TROMETHAMINE | 30MG/ML | injectable · injection | NEPHRON | Prescription | 20 Aug 2020 |
| KETOROLAC TROMETHAMINE | 10MG | tablet · oral | SENORES PHARMS | Prescription | 23 Mar 2022 |
| KETOROLAC TROMETHAMINE | 10MG | tablet · oral | HETERO LABS LTD III | Prescription | 25 Aug 2022 |
| KETOROLAC TROMETHAMINE | 10MG | tablet · oral | ZYDUS LIFESCIENCES | Prescription | 21 Oct 2022 |
43 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACULAR | 01968300 | 0.5 % / W/V | SOLUTION · OPHTHALMIC | ABBVIE CORPORATION |
| ACUVAIL | 02369362 | 0.45 % / W/V | SOLUTION · OPHTHALMIC | ABBVIE CORPORATION |
| APO-KETOROLAC | 02229080 | 10 MG | TABLET · ORAL | APOTEX INC |
| JAMP KETOROLAC | 02510855 | 10 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| KETOROLAC | 02245821 | 0.5 % | SOLUTION · OPHTHALMIC | AA PHARMA INC |
| KETOROLAC TROMETHAMINE INJECTION, USP | 02244947 | 30 MG / ML | LIQUID · INTRAMUSCULAR | FRESENIUS KABI CANADA LTD |
| KETOROLAC TROMETHAMINE INJECTION, USP | 02443376 | 30 MG / ML | SOLUTION · INTRAMUSCULAR | JUNO PHARMA CANADA INC. |
| MAR-KETOROLAC | 02465124 | 10 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| MINT-KETOROLAC | 02461455 | 10 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| TORADOL | 02162660 | 10 MG | TABLET · ORAL | AA PHARMA INC |
| TORADOL IM | 02162644 | 10 MG / ML | SOLUTION · INTRAMUSCULAR | ATNAHS PHARMA UK LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ACULAR LS 0.4% OPHTH SOL | $54.455 | per ML | 23 Sep 2026 |
| US NADAC | KETOROLAC 0.4% OPHTH SOLUTION | $12.67371 | per ML | 23 Sep 2026 |
| US NADAC | KETOROLAC 0.5% OPHTH SOLUTION | $1.45085 | per ML | 23 Sep 2026 |
| US NADAC | KETOROLAC 0.5% OPHTH SOLUTION | $1.33836 | per ML | 23 Sep 2026 |
| US NADAC | KETOROLAC 10 MG TABLET | $0.16448 | per EA | 23 Sep 2026 |
| US NADAC | KETOROLAC 30 MG/ML VIAL | $1.01747 | per ML | 23 Sep 2026 |
| US NADAC | KETOROLAC 60 MG/2 ML VIAL | $0.55237 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Ketorolac 0.5% eye drops | £3.92 | 5 ml | 1 Oct 2026 |
| NHS Drug Tariff | Ketorolac 30mg/1ml solution for injection ampoules | £5.36 | 5 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 18 Sep 2025 ACULAR — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations - US FDA 21 Nov 2024 SPRIX — safety-related labeling change
Labeling sections changed: Boxed Warning; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 24 May 2024 ACUVAIL — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 5 Mar 2021 ACULAR LS — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 8 Dec 2017 OMIDRIA — safety-related labeling change
Labeling sections changed: Adverse Reactions; Use in Specific Populations
Combinations containing Ketorolac
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.